HRAS antibody
Quick Overview for HRAS antibody (ABIN7673381)
Target
See all HRAS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- HRAS-Specific antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- v-Ha-ras Harvey rat sarcoma viral oncogene homolog
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:200-1:1000, IP:1:1000-1:6000, IHC: 1:20-1:200, IF: 1:10-1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Alternative Name
- HRAS
-
Background
- GTPase HRas|H-Ras-1|Ha-Ras|Transforming protein p21|c-H-ras|p21ras|GTPase HRas, N-terminally processed|HRAS|HRAS1
-
Molecular Weight
- 21 kDa
-
Gene ID
- 3265
-
UniProt
- P01112
-
Pathways
- p53 Signaling, MAPK Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Hepatitis C, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Target
-